MedTrace Logo

"Efficacy of Intermittent Enteral Nutrition Versus Continuous Administration in Intensive Care"

NCT05879263 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2023-05-30

No results posted yet for this study

Summary

The goal of this clinical trial is to Determine efficacy of intermittent enteral nutrition vs continuous enteral nutrition in adults patients with a nasogastric tube in a intensive care unit.

The main question\[s\] it aims to answer are:

* Reduction of gastrointestinal and respiratory complications
* Evaluate the achievement of the caloric objective Informed consent will be requested from participants who meet the inclusion criteria.

The participants will be randomized into two groups: control group (continuous enteral nutrition) or experimental group (intermittent enteral nutrition) Researchers will compare intermittent enteral nutrition vs continuous to see if there is a reduction in gastrointestinal and respiratory complications.

Conditions

  • Enteral Nutrition
  • Critical Care
  • Feeding Methods
  • Gastric Feeding Tube

Interventions

OTHER

INTERMITTENT ENTERAL NUTRITITION (IEN)

Administration of Enteral Nutriton (EN) by nasogastric tube in 4 bolus (24h): Duration of the infusion 1hour each shot, using an infusion pump.

OTHER

CONTINUOS ENTERAL NUTRITITION (CEN)

Administration of Enteral Nutriton (EN) by nasogastric tube during 24 hours, using an infusion pump.

Sponsors & Collaborators

  • University of Castilla-La Mancha

    collaborator OTHER

  • Complejo Hospitalario Universitario de Albacete

    lead OTHER

Principal Investigators

  • M.Dolores Saiz-Vinuesa, NURSE · Gerencia de Atención Integrada de Albacete

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-10
Primary Completion
2024-02-29
Completion
2024-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05879263 on ClinicalTrials.gov